Biological functions of exopolysaccharides from probiotic bacteria

Central-European Journal of Immunology

Volumn 36, Issue 1, 2011, Pages 51-55

  Ciszek Lenda, Marta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Biofilm; Exopolysaccharides; Lactobacilli; Probiotic bacteria

Indexed keywords

EXOPOLYSACCHARIDE; PROBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL GENE; BIOFILM; BIOSYNTHESIS; DIARRHEA; DOSE RESPONSE; DRUG MECHANISM; DRUG STRUCTURE; ENTERITIS; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; LACTIC ACID BACTERIUM; LACTOSE INTOLERANCE; MICROBIAL MORPHOLOGY; NONHUMAN; PROBIOTIC LACTIC ACID BACTERIUM; REVIEW;

EID: 79953774735     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Vu B, Chen M, Crawford RJ, Ivanova EP (2009): Bacterial extracellular polysaccharides involved in biofilm formation. Molecules 14: 2535-2554.
2. Salminen S, von Wright A, Morelli L, et al. (1998): Demonstration of safety of probiotics - a review. Int J Food Microbiol 44: 93-106. (Pubitemid 28486945)
3. Fuller R (1989): Probiotics in man and animals. J Appl Bacteriol 66: 365-378.
4. Crittenden RG, Martinez NR, Playne MJ (2003): Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol 80: 217-222. (Pubitemid 35292672)
5. Simmering R, Breves R (2009): Pre- and probiotic cosmetics. Hautarzt 60: 809-814.
6. Dunne C (2001): Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis 7: 136-145.
7. Sengül N, IşIk S, AslIm B, et al. (2010): The effect of exopolysaccharide-producing probiotic strains on gut oxidativ damage in experimental colitis. Dig Dis Sci [Epub ahead of print].
8. Servin AL, Coconnier MH (2003): Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 17: 741-754.
9. Gill HS (2003): Probiotics to enhance anti-infective defenses in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 17: 755-773.
10. Marcinkiewicz J, Ciszek M, Bobek M, et al. (2007): Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int J Exp Pathol 88: 155-164. (Pubitemid 46743988)
11. Matsumoto S, Hara T, Hori T, et al. (2005): Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the downregulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140: 417-426. (Pubitemid 40813951)
12. Cross ML, Ganner A, Teilab D, et al. (2004): Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol Med Microbiol 42: 173-180. (Pubitemid 39208544)
13. Christensen HR, Frøkiaer H, Pestka JJ (2002): Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168: 171-178. (Pubitemid 34014116)
14. Grandy G, Medina M, Soria R, et al. (2010): Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 10: 253.
15. Lee J, Kim Y, Yun HS, et al. (2010): Genetic and proteomic analysis of factors affecting serum cholesterol reduction by Lactobacillus acidophilus A4. Appl Environ Microbiol 76: 4829-4835.
16. Burns AJ, Rowland IR (2000): Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol 1: 13-24.
17. Savilahti E, Kuitunen M, Vaarala O (2008): Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 8: 243-248.
18. Imase K, Tanaka A, Tokunaga K, et al. (2007): Lactobacillus reuteri tablets suppress Helicobacter pylori infection - a double-blind randomised placebo-controlled cross-over clinical study. Kansenshogaku Zasshi 81: 387-393.
19. Sengül N, Aslím B, Uçar G, et al. (2006): Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats. Dis Colon Rectum 49: 250-258. (Pubitemid 43219963)
20. Shanahan F (2002): Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br J Nutr 88: 5-9.
21. Nishimura-Uemura J, Kitazawa H, Kawai Y, et al. (2003): Functional alteration of murine macrophages stimulated with extracellular polysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Food Microbiol 20: 267-273. (Pubitemid 36380471)
22. Makino S, Ikegami S, Kano H, et al. (2006): Immuno-modulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. J Diary Sci 89: 2873-2881. (Pubitemid 44197204)
23. Ruas-Madiedo P, de los Reyes-Gavilán CG (2005): Invited review: methods for the screening, isolation, and characterization of exopolysaccharides produced by lactic acid bacteria. J Dairy Sci 88: 843-856.
24. Salazar N, Ruas-Madiedo P, Kolida S, et al. (2009): Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures. Int J Food Microbiol 135: 260-267.
25. Ruas-Madiedo P, Gueimonde M, Margolles A (2006): Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. Food Prot 69: 2011-2015. (Pubitemid 44384484)
26. Whitfield C (1998): Bacterial extracellular polysaccharides. Can J Microbiol 34: 415-420.
27. Robijn GW, Wienk HL, van den Berg DJ, et al. (1996): Structural studies of the exopolysaccharide produced by Lactobacillus paracasei 34-1. Carbohydr Res 285: 129-139.
28. Górska S, Jachymek W, Rybka J, et al. (2010): Structural and immunochemical studies of neutral exopolysaccharide produced by Lactobacillus johnsonii 142. Carbohydr Res 345: 108-114.
29. Lipiński T, Jones C, Lemercinier X, et al. (2003): Structural analysis of the Lactobacillus rhamnosus strain KL37C exopolysaccharide. Carbohydr Res 338: 605-609. (Pubitemid 36331869)
30. Landersjö C, Yang Z, Huttunen E, Widmalm G (2002): Structural studies of the exopolysaccharide produced by Lactobacillus rhamnosus strain GG (ATCC 53103). Biomacromolecules 3: 880-884.
31. Doco T, Wieruszeski JM, Fournet B, et al. (1990): Structure of an exocellular polysaccharide produced by Streptococcus thermophilus. Carbohydr Res 198: 313-321.
32. Welman AD, Maddox IS (2003): Exopolysaccharides from lactic acid bacteria: perspectives and challenges. Trends Biotechnol 21: 269-274. (Pubitemid 36645214)
33. De Vuyst L, Degeest B (1999): Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol Rev 23: 153-177. (Pubitemid 29189246)
34. Ruas-Madiedo P, Hugenholtz J, Zoon P (2002): An overview of the functionality of exopolysaccharides produced by lactic acid bacteria. Int Dairy J 12: 163-171. (Pubitemid 34234390)
35. Watnick PI, Kolter R (1999): Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol 34: 586-595.
36. Sutherland IW, Vu B, Chen M, et al. (2001): Microbial polysaccharides from Gram-negative bacteria involved in biofilm formation. Int Dairy J 11: 663-674. (Pubitemid 32965018)
37. De Vuyst L, De Vin F, Vaningelgem F, Degeest B (2001): Recent developments in the biosynthesis and applications of heteropolysaccharides from lactic acid bacteria. Int Diary J 11: 687-707. (Pubitemid 32965020)
38. van Kranenburg R, Marugg JD, van Swam II, et al. (1997): Molecular characterization of the plasmid-encoded eps gene cluster essential for exopolysaccharide biosynthesis in Lactococcus lactis. Mol Microbiol 24: 387-397. (Pubitemid 27223868)
39. Stingele F, Neeser JR, Mollet BJ (1996): Identification and characterization of the eps (Exopolysaccharide) gene cluster from Streptococcus thermophilus Sfi6. Bacteriol 178: 1680-1690. (Pubitemid 26085617)
40. Stingele F, Mollet B (1995): Homologous integration and transposition to identify genes involved in the production of exopolysaccharides in Streptococcus thermophilus. Dev Biol Stand 85: 487-493.
41. Griffin AM, Morris VJ, Gasson MJ (1996): The cpsABCDE genes involved in polysaccharide production in Streptococcus salivarius ssp. thermophilus strain NCBF 2393. Gene 183: 23-27. (Pubitemid 27007490)
42. Low D, Ahlgren JA, Horne D, et al. (1998): Role of Streptococcus thermophilus MR-1C capsular exopolysaccharide in cheese moisture retention. Appl Environ Microbiol 64: 2147-2151. (Pubitemid 28252777)
43. Lamothe GT, Jolly L, Mollet B, Stingele F (2002): Genetic and biochemical characterization of exopolysaccharide biosynthesis by Lactobacillus delbrueckii subsp. bulgaricus. Arch Microbiol 178: 218-228. (Pubitemid 34985303)
44. Badel S, Bernardi T, Michaud P (2011): New perspectives for Lactobacilli exopolysaccharides. Biotechnol Adv 29: 54-66.
45. Laws A, Gu Y, Marshall V (2001): Biosynthesis, characterization, and design of bacterial exopolysaccharides from lactic acid bacteria. Biotechnol Adv 19: 597-625. (Pubitemid 34212865)
46. Vuong C, Kocianova S, Voyich JM, et al. (2004): A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 279: 54881-54886. (Pubitemid 40053234)
47. Looijesteijn PJ, Trapet L, De Vries E, et al. (2001): Physiological function of exopolysaccharides produced by Lactococcus lactis. Int J Food Microbiol 64: 71-80. (Pubitemid 32120301)
48. Costerton JW, Geesey GG, Cheng KJ (1978): How bacteria stick. Sci Am 238: 86-95.
49. Watnick P, Kolter R (2000): Biofilm, City of Microbes. J Bacteriol 182: 2675-2679. (Pubitemid 30246894)
50. Byrd MS, Pang B, Mishra M, et al. (2010): The Pseudomonas aeruginosa exopolysaccharide psl facilitates surface adherence and NF-kappaB activation in A549 cells. MBio 1: e00140-10.
51. Herasimenka Y, Cescutti P, Impallomeni G, Rizzo R (2007): Exopolysaccharides produced by Inquilinus limosus, a new pathogen of cystic fibrosis patients: novel structures with usual components. Carbohydr Res 342: 2404-2415. (Pubitemid 47534198)
52. Forde A, Fitzgerald GF (1999): Bacteriophage defence systems in lactic acid bacteria. Antonie Van Leeuwenhoek 76: 89-113. (Pubitemid 29440722)
53. Kumon H (2000): Management of biofilm infections in the urinary tract. World J Surg 24: 1193-1196.
54. Høiby N, Bjarnsholt T, Givskov M, et al. (2010): Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35: 322-332.
55. Burmølle M, Thomsen TR, Fazli M, et al. (2010): Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol 59: 324-336.
56. Vidal K, Donnet-Hughes A, Granato D (2002): Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect Immun 70: 2057-2064. (Pubitemid 34242208)
57. Vinderola G, Perdigón G, Duarte J et al. (2006): Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity Cytokine 36: 254-260.
58. Hosono A, Lee J, Ametani A, et al. (1997): Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Biosci Biotechnol Biochem 61: 312-316. (Pubitemid 27206805)
59. Furukawa N, Matsuoka A, Takahashi T, Yamanaka Y (2000): Anti-metastic effect of kefir grain components on Lewis lung carcinoma and highly metastic B16 melanoma in mice. J Agric Sci Tokyo Nogyo Daigaku 45: 62-70.
60. Kitazawa H, Harata T, Uemura J, et al. (1998): Phosphate group requirement for mitogenic activation of lymphocytes by an extracellular phosphopolysaccharide from Lactobacillus delbrueckii ssp. bulgaricus. Int J Food Microbiol 40: 169-175. (Pubitemid 28234163)
61. Maeda H, Zhu X, Omura K, et al. (2004): Effects of an exopolysaccharide (kefiran) on lipids, blood pressure, blood glucose, and constipation. Biofactors 22: 197-200.
62. Nakajima H, Suzuki Y, Hirota T, et al. (1992): Cholesterol lowering activity of ropy fermented milk. J Food Sci 57: 327-1329.
63. Rodrigues KL, Caputo LR, Carvalho JC, et al. (2005): Antimicrobial and healing activity of kefir and kefiran extract. Int J Antimicrob Agents 25: 404-408. (Pubitemid 40558772)
64. Wu MH, Pan TM, Wu YJ (2010): Exopolysaccharide activities from probiotic bifidobacterium: Immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties. Int J Food Microbiol 144: 104-110.
65. Chabot S, Yu H-Lig, De Léséleu L (2001): Exopolysaccharides from Lactobacillus rhamnosus RW-9595M stimulate TNF, IL-6 and IL-12 in human and mouse cultured immuno competent cells, and IFN-γ in mouse splenocytes. Lait 81: 683-697. (Pubitemid 33586860)
66. Kitazawa H, Yamaguchi T, Fujimoto Y, Itoh T (1993): Comparative activity of B-cell mitogen, a phosphopolysaccharide produced by Lactococcus lactis ssp. cremoris on various lymphocytes. Anim Sci Technol 64: 604-607.
67. Bleau C, Monges A, Rashidan K (2010): Intermediate chains of exopolysaccharides from Lactobacillus rhamnosus RW-9595M increase IL-10 production by macrophages J Appl Microbiol 108: 666-675.
68. Lebeer S, Ceuppens J, Geboes K, et al. (2007): Mechanisms of probiotic-host interaction with IBD as a case study: a role for exopolysaccharides? Commun Agric Appl Biol Sci 72: 41-45.